Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme.

Accidental falls Balance Exercise Feasibility randomised controlled trial Mobility Quality of life Secondary progressive multiple sclerosis Self-management

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
04 Jan 2021
Historique:
received: 14 06 2019
accepted: 23 11 2020
entrez: 4 1 2021
pubmed: 5 1 2021
medline: 5 1 2021
Statut: epublish

Résumé

Balance, mobility impairments and falls are problematic for people with multiple sclerosis (MS). The "Balance Right in MS (BRiMS)" intervention, a 13-week home and group-based exercise and education programme, aims to improve balance and minimise falls. This study aimed to evaluate the feasibility of undertaking a multi-centre randomised controlled trial and to collect the necessary data to design a definitive trial. This randomised controlled feasibility study recruited from four United Kingdom NHS clinical neurology services. Patients ≥ 18 years with secondary progressive MS (Expanded Disability Status Scale 4 to 7) reporting more than two falls in the preceding 6 months were recruited. Participants were block-randomised to either a manualised 13-week education and exercise programme (BRiMS) plus usual care, or usual care alone. Feasibility assessment evaluated recruitment and retention rates, adherence to group assignment and data completeness. Proposed outcomes for the definitive trial (including impact of MS, mobility, quality of life and falls) and economic data were collected at baseline, 13 and 27 weeks, and participants completed daily paper falls diaries. Fifty-six participants (mean age 59.7 years, 66% female, median EDSS 6.0) were recruited in 5 months; 30 randomised to the intervention group. Ten (18%) participants withdrew, 7 from the intervention group. Two additional participants were lost to follow up at the final assessment point. Completion rates were > 98% for all outcomes apart from the falls diary (return rate 62%). After adjusting for baseline score, mean intervention-usual care between-group differences for the potential primary outcomes at week 27 were MS Walking Scale-12v2: - 7.7 (95% confidence interval [CI] - 17.2 to 1.8) and MS Impact Scale-29v2: physical 0.6 (CI - 7.8 to 9), psychological - 0.4 (CI - 9.9 to 9). In total, 715 falls were reported, rate ratio (intervention:usual care) for falls 0.81 (0.41 to 2.26) and injurious falls 0.44 (0.41 to 2.23). Procedures were practical, and retention, programme engagement and outcome completion rates satisfied a priori progression criteria. Challenges were experienced in completion and return of daily falls diaries. Refinement of methods for reporting falls is therefore required, but we consider a full trial to be feasible. ISRCTN13587999 Date of registration: 29 September 2016.

Sections du résumé

BACKGROUND BACKGROUND
Balance, mobility impairments and falls are problematic for people with multiple sclerosis (MS). The "Balance Right in MS (BRiMS)" intervention, a 13-week home and group-based exercise and education programme, aims to improve balance and minimise falls. This study aimed to evaluate the feasibility of undertaking a multi-centre randomised controlled trial and to collect the necessary data to design a definitive trial.
METHODS METHODS
This randomised controlled feasibility study recruited from four United Kingdom NHS clinical neurology services. Patients ≥ 18 years with secondary progressive MS (Expanded Disability Status Scale 4 to 7) reporting more than two falls in the preceding 6 months were recruited. Participants were block-randomised to either a manualised 13-week education and exercise programme (BRiMS) plus usual care, or usual care alone. Feasibility assessment evaluated recruitment and retention rates, adherence to group assignment and data completeness. Proposed outcomes for the definitive trial (including impact of MS, mobility, quality of life and falls) and economic data were collected at baseline, 13 and 27 weeks, and participants completed daily paper falls diaries.
RESULTS RESULTS
Fifty-six participants (mean age 59.7 years, 66% female, median EDSS 6.0) were recruited in 5 months; 30 randomised to the intervention group. Ten (18%) participants withdrew, 7 from the intervention group. Two additional participants were lost to follow up at the final assessment point. Completion rates were > 98% for all outcomes apart from the falls diary (return rate 62%). After adjusting for baseline score, mean intervention-usual care between-group differences for the potential primary outcomes at week 27 were MS Walking Scale-12v2: - 7.7 (95% confidence interval [CI] - 17.2 to 1.8) and MS Impact Scale-29v2: physical 0.6 (CI - 7.8 to 9), psychological - 0.4 (CI - 9.9 to 9). In total, 715 falls were reported, rate ratio (intervention:usual care) for falls 0.81 (0.41 to 2.26) and injurious falls 0.44 (0.41 to 2.23).
CONCLUSIONS CONCLUSIONS
Procedures were practical, and retention, programme engagement and outcome completion rates satisfied a priori progression criteria. Challenges were experienced in completion and return of daily falls diaries. Refinement of methods for reporting falls is therefore required, but we consider a full trial to be feasible.
TRIAL REGISTRATION BACKGROUND
ISRCTN13587999 Date of registration: 29 September 2016.

Identifiants

pubmed: 33390184
doi: 10.1186/s40814-020-00732-9
pii: 10.1186/s40814-020-00732-9
pmc: PMC7780657
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2

Subventions

Organisme : Department of Health
ID : 14/176/12
Pays : United Kingdom

Références

Value Health. 2015 Dec;18(8):1025-36
pubmed: 26686787
Physiother Can. 2009 Spring;61(2):78-87
pubmed: 20190990
BMC Neurol. 2010 Oct 07;10:88
pubmed: 20929556
Mult Scler J Exp Transl Clin. 2016 Apr 5;2:2055217316641130
pubmed: 28607722
Arch Phys Med Rehabil. 2015 Oct;96(10):1898-912
pubmed: 26070975
Value Health. 2015 Dec;18(8):1016-24
pubmed: 26686786
Clin Rehabil. 2007 Sep;21(9):771-81
pubmed: 17875557
Int J MS Care. 2015 Mar-Apr;17(2):65-72
pubmed: 25892976
J Rehabil Med. 2010 Apr;42(4):323-31
pubmed: 20461334
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1092-9
pubmed: 23695501
Arch Phys Med Rehabil. 2014 Mar;95(3):538-45
pubmed: 24055784
Value Health. 2012 Dec;15(8):1084-91
pubmed: 23244811
J Vestib Res. 1996 Sep-Oct;6(5):343-53
pubmed: 9004971
Mult Scler. 2014 Jul;20(8):1112-22
pubmed: 24421303
Neurology. 2003 Jan 14;60(1):31-6
pubmed: 12525714
Mult Scler. 2011 Oct;17(10):1269-72
pubmed: 21642370
Mult Scler J Exp Transl Clin. 2015 Aug 05;1:2055217315596993
pubmed: 28607701
J Rehabil Med. 2012 Oct;44(10):811-23
pubmed: 22990349
Arch Phys Med Rehabil. 2013 Nov;94(11):2157-65
pubmed: 23769764
Clin Trials. 2005;2(2):152-62
pubmed: 16279137
Br J Sports Med. 2006 Dec;40(12):992-7
pubmed: 16980531
Disabil Rehabil. 2018 Sep;40(19):2236-2241
pubmed: 28573883
Mult Scler. 2015 Mar;21(3):263-81
pubmed: 25623244
Int J MS Care. 2014 Winter;16(4):178-84
pubmed: 25694776
Phys Ther. 2013 Feb;93(2):158-67
pubmed: 23023812
Mult Scler. 2013 Dec;19(14):1913-22
pubmed: 23633067
Physiother Res Int. 2016 Jun;21(2):102-8
pubmed: 25782023
PLoS One. 2014 Aug 14;9(8):e104225
pubmed: 25121991
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Int J MS Care. 2014 Winter;16(4):171-7
pubmed: 25694775
BMJ. 2007 Mar 3;334(7591):455-9
pubmed: 17332585
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):841-4
pubmed: 17332049
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
Trials. 2015 Oct 15;16:468
pubmed: 26470880
Brain. 2001 May;124(Pt 5):962-73
pubmed: 11335698
Mult Scler. 2007 Nov;13(9):1168-75
pubmed: 17881391
J Am Geriatr Soc. 2005 Sep;53(9):1618-22
pubmed: 16137297
Pilot Feasibility Stud. 2017 Jul 27;4:26
pubmed: 28770099
Neurol Res. 2006 Jul;28(5):555-62
pubmed: 16808889
Age Ageing. 2005 Nov;34(6):614-9
pubmed: 16267188
Mult Scler. 2012 Mar;18(3):364-71
pubmed: 21952098
Arch Phys Med Rehabil. 2013 May;94(5):883-9
pubmed: 23246897
Am J Public Health. 2008 Aug;98(8):1418-24
pubmed: 18556603
Health Qual Life Outcomes. 2014 May 05;12:66
pubmed: 24886430
J Neurol Sci. 2017 Nov 15;382:131-136
pubmed: 29111007
Clin Rehabil. 2009 Nov;23(11):1018-33
pubmed: 19786420
Age Ageing. 2010 Mar;39(2):210-6
pubmed: 20061508
Mult Scler. 2010 May;16(5):618-26
pubmed: 20207785
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Otol Neurotol. 2013 Aug;34(6):1104-8
pubmed: 23542134
J Clin Epidemiol. 2019 Feb;106:32-40
pubmed: 30266633
Lancet Neurol. 2015 Feb;14(2):194-207
pubmed: 25772898
J Neurol Sci. 2014 Aug 15;343(1-2):3-7
pubmed: 24880538
Mult Scler. 2010 Nov;16(11):1377-84
pubmed: 20699285
Health Technol Assess. 2009 Feb;13(12):iii, ix-x, 1-177
pubmed: 19216837
Disabil Rehabil. 2018 Dec;40(24):2857-2866
pubmed: 28783979

Auteurs

H Gunn (H)

Faculty of Health, School of Health Professions, Peninsula Allied Health Centre, University of Plymouth, Derriford Road, Plymouth, PL6 8BH, England. hilary.gunn100@plymouth.ac.uk.

K N Stevens (KN)

Faculty of Health, Medical Statistics Group, Room N15, Plymouth Science Park, Plymouth, PL6 8BX, England.
Peninsula Clinical Trials Unit, University of Plymouth, Room N16, Plymouth Science Park, Plymouth, PL6 8BX, England.

S Creanor (S)

Faculty of Health, Medical Statistics Group, Room N15, Plymouth Science Park, Plymouth, PL6 8BX, England.
University of Exeter Medical School, College of Medicine & Health, University of Exeter, Exeter, England.

J Andrade (J)

Faculty of Health, School of Psychology, University of Plymouth, Portland Square Building, Drake Circus Campus, Plymouth, PL4 8AA, England.

L Paul (L)

School of Health & Life Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, Scotland.

L Miller (L)

Douglas Grant Rehabilitation Unit, Ayrshire Central Hospital, Kilwinning Road, Irvine, KA12 8SS, Scotland.

C Green (C)

University of Exeter Medical School, Health Economics Group, University of Exeter, St. Luke's Campus, Exeter, EX1 2LU, England.

P Ewings (P)

NIHR Research Design Service (South West), Musgrove Park Hospital, Taunton, TA1 5DA, England.

A Barton (A)

Faculty of Medicine and Dentistry, NIHR Research Design Service South West, ITTC Building, Plymouth Science Park, Plymouth, PL6 8BX, England.

M Berrow (M)

Faculty of Health, Medical Statistics Group, Room N15, Plymouth Science Park, Plymouth, PL6 8BX, England.

J Vickery (J)

Faculty of Health, Medical Statistics Group, Room N15, Plymouth Science Park, Plymouth, PL6 8BX, England.

B Marshall (B)

Faculty of Health, School of Health Professions, Peninsula Allied Health Centre, University of Plymouth, Derriford Road, Plymouth, PL6 8BH, England.

J Zajicek (J)

School of Medicine, Medical and Biological Sciences, University of St. Andrews, North Haugh, St. Andrews, KY16 9TF, Scotland.

J A Freeman (JA)

Faculty of Health, School of Health Professions, Peninsula Allied Health Centre, University of Plymouth, Derriford Road, Plymouth, PL6 8BH, England.

Classifications MeSH